SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers coronavirus tests, and medical and veterinary diagnostics services. SYNLAB AG was founded in 1998 and is headquartered in Munich, Germany.
Stock data | 2024 | Change |
---|---|---|
Price | $12.36 | N/A |
Market Cap | $2.72B | N/A |
Shares Outstanding | 219.71M | N/A |
Employees | 24.91K | N/A |